Prior reports have suggested that RUNX3 is frequently inactivated in human cancer cells and can be activated by hemizygous deletion of the RUNX3 gene, hypermethylation of the Runx3 promoter, or cytoplasmic sequestration of RUNX3 protein 32, 34. This evidence concerns the gene RUNX3 and cancer.